<!DOCTYPE html>

<html>
    <head>
        <title>300x250</title>

        <meta name="ad.size" content="width=300,height=250" />
        <meta name="viewport" content="width=device-width, initial-scale=1" />
        <meta charset="UTF-8" />

        <script>
            var clickTag = "https://www.considernexplanon.com/patient-resources/";
        </script>

        <link rel="stylesheet" href="assets/libs/main.css" />
    </head>

    <body>
        <button style="position:fixed;top:10px;right:10px;padding:8px 12px;background:rgba(0,0,0,0.9);color:white;border:1px solid rgba(255,255,255,0.6);cursor:pointer;font-size:12px;z-index:99999;border-radius:0px;font-family:Arial,sans-serif" onclick="location.href='../../../../index.html#gallery-section'">✕ Cerrar</button>
        <div class="border"></div>
        <div id="merkAdd">
            <a id="clickTag" target="_blank"></a>

            <!-- Frames -->
            <div class="back_all"></div>

            <div class="bg">
                <img src="assets/images/bg.png" />
            </div>
            <div class="bubble_1">
                <img src="assets/images/bubble-1.svg" />
            </div>
            <div class="bubble_2">
                <img src="assets/images/bubble-2.svg" />
            </div>
            <div class="bubble_3">
                <img src="assets/images/bubble-3.svg" />
            </div>
            <div class="square_1"></div>

            <div class="primerFrame">
                <div class="copy1">
                    <p class="name1">
                        Your patients <br />
                        may be asking <br />
                        for long-acting <br />
                        birth control.
                    </p>
                </div>
            </div>

            <div class="tercerFrame" style="opacity: 0;">
                <div class="fondo_03"></div>
                <div class="fondo_03b"></div>

                <div class="bubble_4_y">
                    <img src="assets/images/bubble-4_y.svg" />
                </div>
                <div class="square_2"></div>
                <div class="copy2b">
                    <p class="name2b">
                        Let them know <br />
                        about NEXPLANON
                    </p>
                </div>
            </div>

            <div class="logoFrame">
                <div class="fondo_nex"></div>
                <div class="logo_nex">
                    <img src="assets/images/logo_nex.png" />
                </div>
                <div class="linea_gris"></div>
                <div class="logo_organon">
                    <img src="assets/images/logo_organon.png" />
                </div>
                <div class="copy2">
                    <p class="name2">
                        NEXPLANON is indicated for use<br />
                        by women to prevent pregnancy.
                    </p>
                </div>
            </div>

            <div class="bubble_4_b">
                <img src="assets/images/bubble-4_b.svg" />
            </div>

            <div class="cuartoFrame">
                <div class="copy2c">
                    <p class="name2c">
                        The only non-uterine <br />
                        LARC that provides<span style="letter-spacing: 2px;">...</span>
                    </p>
                </div>
                <div class="copy2d">
                    <p class="name2d">
                        LARC = long-acting reversible <br />
                        contraception.
                    </p>
                </div>
            </div>

            <div class="quintoFrame">
                <div class="text7">
                    <img src="assets/images/text7.png" />
                </div>
                
                <!-- <div class="copy2e">
                    <p class="name2e">
                        <span style="letter-spacing: 2px;">...</span>continuous pregnancy  <br />prevention<span style="letter-spacing: 2px;">...</span>
                    </p>
                </div> -->
            </div>

            <div class="sextoFrame">
                <div class="square_3"></div>

                <div class="text8">
                    <img src="assets/images/text8.png" />
                </div>

                <!-- <div class="copy2g">
                    <p class="name2g">
                        <span style="letter-spacing: 2px;">...</span>for up to 3 years.*
                    </p>
                </div> -->
                <div class="copy2f">
                    <img src="assets/images/leg.png" />
                </div>
            </div>

            <div class="last">
                <div class="fondo_blue"><img src="assets/images/blue.png" /></div>
                <div class="bubble_5">
                    <img src="assets/images/bubble-5.svg" />
                </div>
                <div class="square_4"></div>
                <div class="text9">
                    <img src="assets/images/text9.png" />
                </div>
                <!-- <div class="copylast">
                    <p class="namelast">
                        Get the resources you <br />
                        need for your patients.
                    </p>
                </div> -->
                <div class="cta">
                    <img src="assets/images/cta.svg" />
                </div>
            </div>

            <div id="animation"></div>

            <div id="ssi">
                <div class="title">
                    <h3>Selected Safety Information</h3>
                </div>

                <div class="content">
                    <div class="swiper-container">
                        <div class="top-title" style="display: none;">
                            <div class="title-box">
                                <div class="title1-2">
                                    <h2></h2>
                                </div>
                                <div class="title2-2">
                                    <h2></h2>
                                </div>
                            </div>
                        </div>
                        <div class="swiper-wrapper">
                            <div class="swiper-slide">
                                <div class="slide-inner">
                                    <p style="margin-bottom: 3px;"><strong>Who is not appropriate for NEXPLANON</strong></p>
                                    <ul>
                                        <li style="margin-bottom: 6px;">
                                            NEXPLANON should not be used in women who have known or suspected pregnancy; current or past history of thrombosis or thromboembolic disorders; liver tumors or active liver disease; undiagnosed
                                            abnormal genital bleeding; known or suspected breast cancer, personal history of breast cancer, or other progestin-sensitive cancer now or in the past; or allergy to any component of NEXPLANON.
                                        </li>
                                    </ul>

                                    <p><strong>WARNINGS and PRECAUTIONS</strong></p>
                                    <p><strong>Complications of insertion and removal</strong></p>
                                    <ul>
                                        <li>
                                            Palpate immediately after insertion to ensure proper placement. Undetected failure to insert<br />
                                            the implant may lead to unintended pregnancy.
                                        </li>
                                    </ul>

                                    <ul>
                                        <li>
                                            Insertion and removal-related complications<br />
                                            may include pain, paresthesias, bleeding, hematoma, scarring, or infection. If<br />
                                            NEXPLANON is inserted too deeply (intramuscular or in the fascia), neural<br />
                                            or vascular injury may occur. Implant removal may be difficult or impossible if the implant is not inserted correctly, inserted too deeply, not palpable, encased in fibrous tissue, or has
                                            migrated. If at any time the implant cannot be palpated, it should be localized and removed.
                                        </li>
                                    </ul>

                                    <ul>
                                        <li>
                                            There have been postmarketing reports of implants located within the vessels of the arm<br />
                                            and the pulmonary artery; in these cases, endovascular or surgical procedures may be needed for removal.
                                        </li>
                                    </ul>

                                    <ul>
                                        <li style="margin-bottom: 6px;">
                                            Failure to remove the implant may result in continued effects of etonogestrel, such as compromised fertility, ectopic pregnancy, or persistence or occurrence of a drug-related adverse event.
                                        </li>
                                    </ul>

                                    <p><strong>NEXPLANON and pregnancy</strong></p>
                                    <ul>
                                        <li>
                                            Should pregnancy or lower abdominal pain<br />
                                            occur while using NEXPLANON, be alert to the possibility of an ectopic pregnancy.
                                        </li>
                                    </ul>
                                    <ul>
                                        <li style="margin-bottom: 6px;">
                                            <strong>Rule out pregnancy before inserting NEXPLANON.</strong>
                                        </li>
                                    </ul>

                                    <p><strong>Educate her about the risk of serious vascular events</strong></p>
                                    <ul>
                                        <li>
                                            There have been postmarketing reports of serious arterial thrombotic and venous thromboembolic events, including cases of pulmonary emboli (some fatal), deep vein thrombosis, myocardial
                                            infarction, and strokes,<br />
                                            in women using etonogestrel implants. Assess women with known risk factors. NEXPLANON should be removed if thrombosis occurs.
                                        </li>
                                    </ul>
                                    <ul>
                                        <li>
                                            NEXPLANON should not be used prior to 21<br />
                                            days postpartum due to risk of<br />
                                            thromboembolism.
                                        </li>
                                    </ul>
                                    <ul>
                                        <li>
                                            Women with a history of thromboembolic disorders should be made aware of the<br />
                                            possibility of a recurrence.
                                        </li>
                                    </ul>
                                    <ul>
                                        <li style="margin-bottom: 6px;">
                                            In case of long-term immobilization, consider removing NEXPLANON.
                                        </li>
                                    </ul>

                                    <p><strong>Counsel her about changes in bleeding patterns</strong></p>
                                    <ul>
                                        <li style="margin-bottom: 6px;">
                                            Women are likely to have changes in their menstrual bleeding pattern with NEXPLANON, including changes in frequency, intensity, or duration. Evaluate abnormal bleeding as needed to exclude
                                            pathologic conditions or pregnancy.<br />
                                            In clinical studies of the non-radiopaque etonogestrel implant, the most common reason for discontinuation was changes in bleeding patterns (11.1%).
                                        </li>
                                    </ul>

                                    <p><strong>Be aware of other serious complications, adverse reactions, and drug interactions</strong></p>
                                    <ul>
                                        <li>
                                            Remove NEXPLANON if jaundice occurs or<br />
                                            blood pressure rises significantly and becomes uncontrolled.
                                        </li>
                                    </ul>
                                    <ul>
                                        <li>
                                            Monitor prediabetic and diabetic women using NEXPLANON.
                                        </li>
                                    </ul>
                                    <ul>
                                        <li>
                                            Observe women with a history of depressed mood. Consider removing NEXPLANON in patients who become significantly depressed.
                                        </li>
                                    </ul>
                                    <ul>
                                        <li>
                                            The most common adverse reactions (≥10%) reported in clinical trials were headache (24.9%), vaginitis (14.5%), weight increase (13.7%), acne (13.5%), breast pain (12.8%), abdominal pain (10.9%),
                                            and pharyngitis (10.5%).
                                        </li>
                                    </ul>
                                    <ul>
                                        <li>
                                            Drugs or herbal products that induce enzymes, including CYP3A4, may decrease the effectiveness of NEXPLANON or increase breakthrough bleeding.
                                        </li>
                                    </ul>
                                    <ul>
                                        <li>
                                            The efficacy of NEXPLANON in women<br />
                                            weighing more than 130% of their ideal body weight has not been studied. Serum concentrations of etonogestrel are inversely related to body weight and decrease with time after implant insertion.
                                            NEXPLANON may be<br />
                                            less effective in overweight women.
                                        </li>
                                    </ul>
                                    <ul>
                                        <li>
                                            NEXPLANON does not protect against HIV or other STDs.
                                        </li>
                                    </ul>

                                    <p style="margin-bottom: 6px; color: #000;">
                                        <strong>
                                            Before prescribing NEXPLANON, please read the accompanying <a href="https://www.organon.com/product/usa/pi_circulars/n/nexplanon/nexplanon_pi.pdf" target="_blank">Prescribing Information</a>.
                                            <br />
                                            The <a href="https://www.organon.com/product/usa/pi_circulars/n/nexplanon/nexplanon_ppi.pdf" target="_blank">Patient Information</a> also is available.
                                        </strong>
                                    </p>

                                    <p style="color: #000; margin-bottom: 10px;">
                                        &copy; 2022 Organon group of companies. All rights<br />
                                        reserved. ORGANON and the ORGANON Logo<br />
                                        are trademarks of the Organon group of<br />
                                        companies. US-XPL-116492 12/22
                                    </p>

                                    <img style="margin-bottom: 6px;" src="assets/images/logo_organon_final.svg" />
                                </div>
                            </div>
                        </div>
                    </div>
                    <div class="swiper-scrollbar"></div>
                    <div class="top-button" style="display: none;"></div>
                    <div class="bottom-button" style="display: none;"></div>
                </div>

                <div class="footer">
                    <a href="https://www.organon.com/product/usa/pi_circulars/n/nexplanon/nexplanon_pi.pdf" target="_blank">Please see full Prescribing Information</a>
                    <!-- <a class="pi_link" onclick="openPI()" target="_blank">Please see full Prescribing Information</a> -->
                </div>
            </div>
        </div>

        <script type="text/javascript" src="assets/libs/gsap3.8.0.js"></script>
        <script type="text/javascript" src="assets/libs/swiper.4.0.2.js"></script>

        <script src="main.js"></script>

        <script>
            clickTag = "https://www.considernexplanon.com/patient-resources/";

            var bannerTag = document.getElementById("clickTag");
            var btnCTA = document.getElementById("mainBtn");

            bannerTag.addEventListener("click", onClickBanner);

            function onClickBanner() {
                gotoLink();
            }

            function onClickCta() {
                gotoLink();
            }

            function gotoLink() {
                window.open(clickTag, "_blank");
            }
        </script>
    </body>
</html>
